Skip to search formSkip to main contentSkip to account menu

Ki-67 Antigen

Known as: KIA, MIB 1 Antigen, Antigen, MIB-1 
A CELL CYCLE and tumor growth marker which can be readily detected using IMMUNOCYTOCHEMISTRY methods. Ki-67 is a nuclear antigen present only in the… 
National Institutes of Health

Related topics

Related topics

16 relations
Cell Cycle ControlCell NucleusCell ProliferationFHA Domain

Broader (2)

Neoplasm ProteinsNuclear Proteins

Narrower (1)

chmadrin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Adult B-Cell Lymphomas With Burkitt-Like Morphology Are Phenotypically and Genotypically Heterogeneous With Aggressive Clinical Behavior
Adult, de novo B-cell lymphomas meeting the WHO morphologic criteria for atypical Burkitt/Burkitt-like lymphoma cause diagnostic… 
Highly Cited
2005
Highly Cited
2005
The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma.
BACKGROUND Although many histopathologic characteristics of oral squamous cell carcinoma (O-SCC) have been identified as… 
Review
2002
Review
2002
Impact of Proliferation Index on Outcome in Childhood Malignant Gliomas: Results in a Multi-institutional Cohort
OBJECTIVE Prognoses of pediatric high-grade gliomas are unpredictable, even when clinical and histological factors are taken into… 
Highly Cited
2002
Highly Cited
2002
Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder
Recurrence of transitional cell carcinoma of the bladder cannot be predicted accurately by traditional criteria alone. This study… 
Review
2000
Review
2000
Markers of proliferation in normal and leukoplakic oral epithelia.
Highly Cited
2000
Highly Cited
2000
Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer.
Highly Cited
1999
Highly Cited
1999
Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer.
PURPOSE To investigate the hypothesis that in vitro bromodeoxyuridine (BrDu) labeling might be superior to MIB-1 immunostaining… 
Highly Cited
1996
Highly Cited
1996
Relationship between p53 gene abnormalities and other tumour characteristics in breast‐cancer prognosis
The prognostic significance of p53 gene abnormalities was investigated in 919 primary breast‐cancer patients. p53 expression and… 
Highly Cited
1994
Highly Cited
1994
Correlation between the bromodeoxyuridine labeling index and the MIB‐1 and Ki‐67 proliferating cell indices in cerebral gliomas
Background. Recently, it has been shown that heating paraffin embedded tumor sections in a microwave oven can reactivate an… 
Highly Cited
1993
Highly Cited
1993
Prognostic significance of Ki-67 immunostaining in nonmetastatic renal cell carcinoma.
PURPOSE Fresh tissue samples from nonmetastatic renal cell carcinoma (RCC) patients were analyzed by Ki-67 immunostaining to… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)